A HCBP1 peptide conjugated ruthenium complex for targeted therapy of hepatoma.
Sign Up to like & getrecommendations! Published in 2020 at "Dalton transactions"
DOI: 10.1039/c9dt03856f
Abstract: An HCBP1 peptide-ruthenium conjugate (Ru-β-Ala-FQHPSFI) as a potential candidate for targeted therapy of hepatoma was synthesized. Ru-β-Ala-FQHPSFI shows drastically enhanced cytotoxicity and high selectivity for hepatoma cells versus noncancer liver cells. Raman imaging shows that… read more here.
Keywords: ruthenium; hepatoma; targeted therapy; therapy hepatoma ... See more keywords